Platinum Investment Management’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-222,222
Closed -$13.8M 155
2023
Q4
$13.8M Hold
222,222
0.56% 32
2023
Q3
$4.93M Buy
+222,222
New +$4.67M 0.19% 51

Platinum Investment Management's RYZB Position: Q1 2024 in Review

Platinum Investment Management sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 222,222 shares — an estimated $13.8M sold.

Platinum Investment Management first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $13.8M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

  • Platinum Investment Management reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Platinum Investment Management sold 222,222 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $13.8M.
  • Platinum Investment Management first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • Platinum Investment Management's RayzeBio, Inc. Common Stock position peaked at $13.8M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Platinum Investment Management's 13F filing for Q1 2024, filed 13 May 2024.